Rigel Pharmaceuticals (RIGL) Deferred Taxes (2026)

Rigel Pharmaceuticals (RIGL) recorded quarterly Deferred Taxes of $2.6 million in Q1 2026.

Rigel Pharmaceuticals (RIGL) Deferred Taxes (2026) Analysis & Trends

Rigel Pharmaceuticals' Deferred Taxes history runs 1 years deep, the most recent figure standing at $2.6 million for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -859,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -65.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Rigel Pharmaceuticals 603.18 Mn 456.49 Mn 54.21 Mn 2.57 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.57 Mn